Skip to main content
Year archive

BRAIN Biotech AG — 2024 filings

All 32 regulatory filings released by BRAIN Biotech AG (BNN) in 2024, sourced directly from the official regulator.

32 Filings
2024 Period
2024 filings (32)
Filing Released Lang
BRAIN Biotech AG Sharpens Focus on Profitable Growth
Regulatory Filings
2024-12-13 English
BRAIN Biotech AG Sharpens Focus on Profitable Growth
Regulatory Filings
2024-12-12 English
Prof. Dr. Wiltrud Treffenfeldt leaves Supervisory Board of BRAIN Biotech AG for personal reasons
Board/Management Information
2024-10-03 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements
2024-09-27 German
BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Regulatory Filings
2024-09-20 English
BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
Capital/Financing Update
2024-09-20 English
BRAIN Biotech AG presents strong cash position with its 9M reporting and is forecasting good sequential growth in the final quarter of the business year
Earnings Release 9M 2024
2024-08-29 English
Q3 statement / Q3 financial report 2023/2024
Interim / Quarterly Report Q2 2024
2024-08-29 English
BRAIN Biotech AG announces the appointment of Erik de Vries as Senior Business Development Director Enzymes
Board/Management Information
2024-05-29 English
BRAIN Biotech AG receives major milestone payment and stays on-track to achieve year end targets
Earnings Release H1 2024
2024-05-28 English
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.10.2023 bis zum 31.03.2024
Interim / Quarterly Report H1 2024
2024-05-28 German
Half-yearly financial report 2023/2024
Interim / Quarterly Report H1 2024
2024-05-28 English
Report Publication Announcement 2024
Report Publication Announcement
2024-05-14 English
Hinweis auf Halbjahresfinanzbericht vom 01.10.2023 bis zum 31.03.2024
Report Publication Announcement
2024-05-14 German
Hinweis auf Halbjahresfinanzbericht vom 01.10.2023 bis zum 31.03.2024
Report Publication Announcement
2024-05-14 German
BRAIN Biotech AG takes next step to optimize group structure
Regulatory Filings
2024-04-16 English
Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams
Environmental & Social Information
2024-03-14 English
Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG
AGM Information
2024-03-12 English
Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials
Environmental & Social Information
2024-03-05 English
BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives
Capital/Financing Update
2024-02-29 English
BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights
Capital/Financing Update
2024-02-29 English
3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24
Earnings Release Q1 2024
2024-02-28 English
Q1 statement / Q1 financial report 2023/2024
Interim / Quarterly Report Q4 2023
2024-02-28 English
Konzernabschluss zum Geschäftsjahr vom 01.10.2022 bis zum 30.09.2023
Annual Report (ESEF) FY 2023
2024-02-01 German
Jahresabschluss zum Geschäftsjahr vom 01.10.2022 bis zum 30.09.2023
Interim / Quarterly Report FY 2023
2024-02-01 German
Annual financial report 2022/2023
Annual Report FY 2023
2024-01-26 English
BRAIN Biotech AG: Bekanntmachung der Einberufung zur Hauptversammlung am 12.03.2024 in Zwingenberg mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2024-01-24 German
Annual Report 2022/23: BRAIN Biotech AG successfully executes growth strategy
Earnings Release FY 2023
2024-01-17 English
Report Publication Announcement 2024
Report Publication Announcement
2024-01-10 English
Hinweis auf Jahresfinanzbericht vom 01.10.2022 bis zum 30.09.2023
Report Publication Announcement
2024-01-10 German
Hinweis auf Konzernabschluss vom 01.10.2022 bis zum 30.09.2023
Report Publication Announcement
2024-01-10 German
Hinweis auf Jahresfinanzbericht vom 01.10.2022 bis zum 30.09.2023
Report Publication Announcement
2024-01-10 German